Revenue $5.36B, up 4.9% on a year earlier. Diluted EPS $0.86 against $0.91.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $5.36B | $5.32B | $5.11B | +4.9% |
| Operating income | $1.02B | $964.00M | $1.08B | -5.9% |
| Net income | $693.00M | $646.00M | $743.00M | -6.7% |
| Diluted EPS | $0.86 | $0.80 | $0.91 | |
| Operating cash flow | $995.00M | $747.00M | $884.00M | +12.6% |
| Capital expenditures | -$128.00M | -$138.00M | -$108.00M | |
| Free cash flow | $867.00M | $609.00M | $776.00M | +11.7% |
| Dividend per share | $0.53 | $0.53 | $0.52 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Latin America organic sales growth | 5.3% | 3.4% | |
| Organic sales growth | 2.4% | 1.8% | |
| Hill's Pet Nutrition Organic sales growth | 2.1% | 2% | |
| North America organic sales growth | -3% | -0.9% | |
| Europe Organic Sales Growth | 2% | 2% | |
| Working capital as % of Net sales | -5.9% | -2.9% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Colgate Palmolive (CL) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/CL/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
